A low-cost Ayurvedic medicine has been developed by the Council for Scientific and Industrial Research (CSIR) along with two other organisations for diabetes patients.
The medicine named “BGR—34” has been developed jointly by CSIR—NBRI (National Botanical Research Institute) Lucknow and CSIR—CIMAP (Central Institute of Medicinal & Aromatic Plants (Lucknow).
The medicine was launched here yesterday at the presence of A K S Rawat—Principal Senior Scientist CSIR— National Botanical Research Institute, Lucknow and D N Mani Senior Scientist CSIR—Central Institute for Medicinal And Aromatic Plants, Lucknow.
It would help maintain normal Blood Glucose Metabolism and also reduce chances of long term complications, they said.
AIMIL Pharmaceuticals, a private company, has been given the marketing right of the Ayurvedic proprietary medicine, a company release said.
See below more newspaper coverage: